Journal
EMERGING INFECTIOUS DISEASES
Volume 22, Issue 3, Pages 511-514Publisher
CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2203.150828
Keywords
-
Categories
Funding
- National Institutes of Health training grant [2T32 HL083808-06]
- Centers for Disease Control and Prevention [FOA CK11-1102]
Ask authors/readers for more resources
Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting effective drugs or dosing regimens are limited. To better identify treatment approaches and associated toxicities, we collected a series of case reports from the Emerging Infections Network. Side effects were common and often led to changing or discontinuing therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available